108 related articles for article (PubMed ID: 17387782)
41. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
Thomas TL
Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
[TBL] [Abstract][Full Text] [Related]
42. Adolescent girls' preferences for HPV vaccines: a discrete choice experiment.
Brown DS; Poulos C; Johnson FR; Chamiec-Case L; Messonnier ML
Adv Health Econ Health Serv Res; 2014; 24():93-121. PubMed ID: 25244906
[TBL] [Abstract][Full Text] [Related]
43. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?
Kepka D; Berkowitz Z; Yabroff KR; Roland K; Saraiya M
Sex Transm Infect; 2012 Oct; 88(6):433-5. PubMed ID: 22522751
[TBL] [Abstract][Full Text] [Related]
44. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.
Grant LA; Dunne EF; Chesson H; Markowitz LE
Vaccine; 2011 Mar; 29(13):2365-70. PubMed ID: 21277406
[TBL] [Abstract][Full Text] [Related]
45. The cost-effectiveness of male HPV vaccination in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus vaccine coverage.
Yuji K; Matsumura T; Miyano S; Tsuchiya R; Kami M
Lancet; 2010 Jul; 376(9738):329-30; author reply 330. PubMed ID: 20674715
[No Abstract] [Full Text] [Related]
47. A critique of criteria for evaluating vaccines for inclusion in mandatory school immunization programs.
Opel DJ; Diekema DS; Marcuse EK
Pediatrics; 2008 Aug; 122(2):e504-10. PubMed ID: 18676536
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus vaccine acceptability among a national sample of adult women in the USA.
Stupiansky NW; Rosenthal SL; Wiehe SE; Zimet GD
Sex Health; 2010 Sep; 7(3):304-9. PubMed ID: 20719219
[TBL] [Abstract][Full Text] [Related]
49. Recent developments in health law.
Ang CP; Wolpin J; Baron E
J Law Med Ethics; 2009; 37(1):149-59. PubMed ID: 19245612
[No Abstract] [Full Text] [Related]
50. HPV vaccine: beyond the hype.
Consum Rep; 2007 Oct; 72(10):47. PubMed ID: 17912799
[No Abstract] [Full Text] [Related]
51. Human papillomavirus vaccines: factors that affect vaccine knowledge and delivery.
Holder NA; Katzenellenbogen R; Middleman AB
J Adolesc Health; 2013 Sep; 53(3):423-5. PubMed ID: 23830089
[TBL] [Abstract][Full Text] [Related]
52. Immune deficiency. Why a measles vaccine has presidential wannabes talking in code.
Scherer M
Time; 2015 Feb; 185(5):12. PubMed ID: 25816464
[No Abstract] [Full Text] [Related]
53. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
Watson M; Shaw D; Molchanoff L; McInnes C
Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
[TBL] [Abstract][Full Text] [Related]
54. Three provinces to study 2-dose HPV vaccine.
Eggertson L
CMAJ; 2007 Aug; 177(5):444-5. PubMed ID: 17724315
[No Abstract] [Full Text] [Related]
55. Impact of vaccinating boys and men against HPV in the United States.
Elbasha EH; Dasbach EJ
Vaccine; 2010 Oct; 28(42):6858-67. PubMed ID: 20713101
[TBL] [Abstract][Full Text] [Related]
56. Has the spread of HPV vaccine marketing conveyed immunity to common sense?
McGee G; Johnson S
Am J Bioeth; 2007 Jul; 7(7):1-2. PubMed ID: 17654367
[No Abstract] [Full Text] [Related]
57. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
[TBL] [Abstract][Full Text] [Related]
58. Doctors fighting backlash over vaccines.
Pollak M
N Y Times Web; 1999 Apr; ():F7. PubMed ID: 11648113
[No Abstract] [Full Text] [Related]
59. HPV vaccine implementation in STD clinics--STD Surveillance Network.
Meites E; Llata E; Hariri S; Zenilman J; Longfellow L; Schwebke J; Tabidze I; Mettenbrink C; Jenkins H; Guerry S; Pathela P; Asbel L; Stover JA; Bernstein K; Kerani RP; Dunne EF; Markowitz LE
Sex Transm Dis; 2012 Jan; 39(1):32-4. PubMed ID: 22183843
[TBL] [Abstract][Full Text] [Related]
60. Update on vaccination clinical trials for HPV-related disease.
Erickson BK; Landers EE; Huh WK
Clin Ther; 2014 Jan; 36(1):8-16. PubMed ID: 24417781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
